Albert Boerla wins Genesis Prize 2022

Category : Awards Published on: January 22 2022

Share on facebook

The global pharmaceutical giant Pfizer Inc.’s Chairman and Chief Executive, Albert Bourla, has been awarded with the prestigious Genesis Prize 2022 on January 19, 2022.
He has been awarded for his efforts in leading the development of a COVID-19 vaccine (Pfizer–BioNTech COVID-19 vaccine).
The cash prize of this award is $1 million.
The annual prize is awarded to Jewish people who have achieved significant professional success, in recognition of their accomplishments, contributions to humanity, and commitment to Jewish values and/or to the State of Israel.
It is widely referred to as the “Jewish Nobel Prize”.

SBI Research has projected India’s GDP growth for FY26 at around 7.5%, with first advance estimates placing growth at 7.4%.
Read More....
Akasa Air has become India’s fifth airline to join IATA after qualifying for the IATA Operational Safety Audit.
Read More....
The United Nations has projected that India’s GDP growth may moderate to 6.6% in 2026 due to global trade pressures.
Read More....
UIDAI has launched ‘Udai’ as the official Aadhaar mascot to make Aadhaar services more citizen-friendly.
Read More....
Women and Child Development Minister Annapurna Devi launched the ‘PANKHUDI’ portal to strengthen coordination in women and child welfare schemes.
Read More....
Five sewerage infrastructure projects were commissioned under Namami Gange Phase II, raising total treatment capacity to 3,976 MLD.
Read More....
Somnath Swabhiman Parv will be observed in January 2026 to commemorate 1,000 years of faith and resilience linked to the Somnath Temple.
Read More....
National Youth Day will be celebrated on 12 January 2026 to mark the birth anniversary of Swami Vivekananda.
Read More....
Asian Games gold medallist and national record-holder Jinson Johnson has announced his retirement from competitive athletics.
Read More....
Kerala has redesignated Aralam Wildlife Sanctuary as the State’s first Butterfly Sanctuary.
Read More....